Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.

ACS chemical biology (2018)

Terai, et al.

材料

产品编号

品牌

产品描述

Sigma-Aldrich

ALW-II-41-27, ≥98% (HPLC)